Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRIW) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for Biofrontera (BFRIW) over the last 6 years, with Q3 2025 value amounting to $10.8 million.

  • Biofrontera's Shares Outstanding (Weighted Average) rose 8664.27% to $10.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year increase of 8664.27%. This contributed to the annual value of $5.5 million for FY2024, which is 25674.48% up from last year.
  • Per Biofrontera's latest filing, its Shares Outstanding (Weighted Average) stood at $10.8 million for Q3 2025, which was up 8664.27% from $9.4 million recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Shares Outstanding (Weighted Average) peaked at $17.1 million during Q1 2022, and registered a low of $941175.0 during Q2 2022.
  • For the 5-year period, Biofrontera's Shares Outstanding (Weighted Average) averaged around $5.7 million, with its median value being $5.5 million (2024).
  • As far as peak fluctuations go, Biofrontera's Shares Outstanding (Weighted Average) surged by 79990000.0% in 2021, and later plummeted by 9219.54% in 2023.
  • Over the past 5 years, Biofrontera's Shares Outstanding (Weighted Average) (Quarter) stood at $8.8 million in 2021, then crashed by 88.0% to $1.1 million in 2022, then soared by 46.29% to $1.5 million in 2023, then skyrocketed by 256.74% to $5.5 million in 2024, then soared by 95.36% to $10.8 million in 2025.
  • Its last three reported values are $10.8 million in Q3 2025, $9.4 million for Q2 2025, and $8.9 million during Q1 2025.